$LMNR

Limoneira CO (LMNR): Results of Operations and Financial Condition

Limoneira CO (LMNR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 lmnr43026erex991.htm EX-99.1 Document Exhibit 99.1 Limoneira Company Announces Second Quarter Fiscal Year 2026 Financial Results Reports Second Quarter Revenue of $23.9 Million, Exceeding Expectations Full Year Fiscal 2026 Avocado Volume Guidance Increased to 5.5 Millio

Original reporting
Published Jun 9, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LMNR
Bullish
medium confidence
Mentioned
$LMNR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LMNRBullishMed
01

Why it matters

The 8-K provides a fresh earnings snapshot, a specific full-year avocado volume guidance increase, and concrete asset/strategy actions (Agromin JV, $16M Paso Robles partial sale, Arizona citrus exit, and water monetization expected in FY2026).

02

Market read

Traders get actionable updates on FY2026 operational trajectory (avocado volume) and monetization milestones that can re-rate expectations for future adjusted EBITDA.

03

What to watch

Investors may discount the guidance if seasonality (Q3/Q4 lemon volumes under Sunkist) delays cash generation, and if impairment/cost items indicate underlying asset pressure rather than one-off effects.

Relevance 7/10Novelty 8/10Timing: after-hours / filed 2026-06-09

Background

Limoneira is executing a “value creation” strategy combining agriculture income growth with monetization of land and water assets, including a lemon sales/marketing shift to Sunkist.

Company-level read

Ticker impact

$LMNRBullishMedium confidence
Context

Limoneira reported FY2026 Q2 results and raised full-year avocado volume guidance to 5.5–6.5 million pounds, plus disclosed an Agromin JV and $16M Paso Robles partial sale.

Expected impact

Near-term bias upward if investors focus on raised avocado volume and monetization progress; downside risk if the revenue decline and higher costs/impairments dominate.

Evidence & confidence

The filing is a fresh 8-K with specific operational guidance and deal/asset actions (Agromin JV, $16M partial sale, Arizona citrus exit, water monetization on track). However, the quarter shows a sizable YoY revenue decline and higher costs, which can temper the reaction.

Market effects

Signals continued consolidation/optimization in US produce/agribusiness models (partnerships, land/water monetization) that can influence read-across sentiment for small-cap ag operators.

Limited; primarily affects California agribusiness and local agricultural supply-chain sentiment.

Low; largely company-specific within specialty citrus/avocado supply chains.

Counterpoint

The raised avocado volume guidance may not fully offset the reported YoY revenue contraction and higher costs/impairments, so the market could treat this as execution progress rather than immediate earnings upside.

Key entities

  • Limoneira Company

    Nasdaq-listed diversified lemon and avocado grower/packer reporting FY2026 Q2 results and updated guidance.

  • Agromin joint venture

    JV agreement executed to create a high-return platform using underutilized land and conserved water.

  • Sunkist partnership

    Lemon sales/marketing structure expected to shift quarterly sales cadence toward stronger Q3/Q4 volumes.

Related articles

$LMNRMed

Limoneira (LMNR) Leans On Avocados And Land Deals As Lemons Slump

Limoneira (LMNR) reported Q3 revenue of $43.8M, down from $47.5M YoY, but adjusted EBITDA rose to $3.9M. Lemon prices increased, and avocado volume surpassed expectations. The company is focusing on selling land, water rights, and real estate, targeting $200M in proceeds. Long-term debt rose to $100.7M, and GAAP net loss widened to $0.17 per share.

$LMNRMed

Limoneira Co (LMNR) (Q3 2026) Earnings Call Highlights: Revenue Slips but Avocado Outlook Brightens

Limoneira Co (LMNR) reported Q3 2026 revenue of $43.8M, down from $47.5M YoY, with a net loss of $3.0M. Adjusted EBITDA rose to $3.9M. Avocado volume guidance increased to 7.0-7.25M lbs for 2026 and over 10M lbs for 2027. Lemon volume guidance was lowered due to higher imports. The company plans to sell Windfall Farms for $15M and monetize water rights. CEO Harold Edwards expects stronger EBITDA in 2027 driven by avocado growth and cost savings.

$LMNRMed

Limoneira CO (LMNR): Results of Operations and Financial Condition

Limoneira CO (LMNR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Limoneira Company Announces Third Quarter Fiscal Year 2026 Financial Results Third Quarter Total Net Revenues of $43.8 Million Entered Agreement to Sell Windfall Farms Vineyard Property for $15.0 Million All-Cash Via Competitive Public Auction Water Monetization Stra

$TSLAHighAI 9/10

Tesla Posted Negative $1.1 Billion in Free Cash Flow Last Quarter as Elon Musk Ramps Up Spending on Robotaxis and Optimus. Here's Why the Company's $43.5 Billion Cash Cushion Still Matters.

Tesla reported a 26% revenue increase to $22.5B in Q2, with net income of $1.11B, but negative free cash flow of $1.1B due to $5.79B in capital expenditures. The company's $43.5B cash position provides a buffer for growth investments in robotaxis, Optimus robots, and semiconductors. Tesla's market share in U.S. EVs has risen despite industry contraction, but competition from Chinese rivals like BYD persists.

$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.